List of Tables
Table 1. Covid-19 Therapeutic Market Trends
Table 2. Covid-19 Therapeutic Market Drivers & Opportunity
Table 3. Covid-19 Therapeutic Market Challenges
Table 4. Covid-19 Therapeutic Market Restraints
Table 5. Global Covid-19 Therapeutic Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Covid-19 Therapeutic Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Covid-19 Therapeutic Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Covid-19 Therapeutic Product Type
Table 9. Key Companies Time to Begin Mass Production of Covid-19 Therapeutic
Table 10. Global Covid-19 Therapeutic Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Therapeutic as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Covid-19 Therapeutic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Covid-19 Therapeutic Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Covid-19 Therapeutic Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Covid-19 Therapeutic Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Covid-19 Therapeutic Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Covid-19 Therapeutic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Covid-19 Therapeutic Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Covid-19 Therapeutic Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Covid-19 Therapeutic Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Covid-19 Therapeutic Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Covid-19 Therapeutic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Covid-19 Therapeutic Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Covid-19 Therapeutic Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Covid-19 Therapeutic Sales Value by Region (2019-2024) & (%)
Table 27. Global Covid-19 Therapeutic Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Covid-19 Therapeutic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Covid-19 Therapeutic Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Covid-19 Therapeutic Sales Value, (2025-2030) & (US$ Million)
Table 31. Cadila Healthcare Basic Information List
Table 32. Cadila Healthcare Description and Business Overview
Table 33. Cadila Healthcare Covid-19 Therapeutic Products, Services and Solutions
Table 34. Revenue (US$ Million) in Covid-19 Therapeutic Business of Cadila Healthcare (2019-2024)
Table 35. Cadila Healthcare Recent Developments
Table 36. Johnson & Johnson Basic Information List
Table 37. Johnson & Johnson Description and Business Overview
Table 38. Johnson & Johnson Covid-19 Therapeutic Products, Services and Solutions
Table 39. Revenue (US$ Million) in Covid-19 Therapeutic Business of Johnson & Johnson (2019-2024)
Table 40. Johnson & Johnson Recent Developments
Table 41. ImmunoPrecise Basic Information List
Table 42. ImmunoPrecise Description and Business Overview
Table 43. ImmunoPrecise Covid-19 Therapeutic Products, Services and Solutions
Table 44. Revenue (US$ Million) in Covid-19 Therapeutic Business of ImmunoPrecise (2019-2024)
Table 45. ImmunoPrecise Recent Developments
Table 46. Novartis Basic Information List
Table 47. Novartis Description and Business Overview
Table 48. Novartis Covid-19 Therapeutic Products, Services and Solutions
Table 49. Revenue (US$ Million) in Covid-19 Therapeutic Business of Novartis (2019-2024)
Table 50. Novartis Recent Developments
Table 51. AstraZeneca Basic Information List
Table 52. AstraZeneca Description and Business Overview
Table 53. AstraZeneca Covid-19 Therapeutic Products, Services and Solutions
Table 54. Revenue (US$ Million) in Covid-19 Therapeutic Business of AstraZeneca (2019-2024)
Table 55. AstraZeneca Recent Developments
Table 56. Cipla Basic Information List
Table 57. Cipla Description and Business Overview
Table 58. Cipla Covid-19 Therapeutic Products, Services and Solutions
Table 59. Revenue (US$ Million) in Covid-19 Therapeutic Business of Cipla (2019-2024)
Table 60. Cipla Recent Developments
Table 61. AbbVie Basic Information List
Table 62. AbbVie Description and Business Overview
Table 63. AbbVie Covid-19 Therapeutic Products, Services and Solutions
Table 64. Revenue (US$ Million) in Covid-19 Therapeutic Business of AbbVie (2019-2024)
Table 65. AbbVie Recent Developments
Table 66. Bayer Basic Information List
Table 67. Bayer Description and Business Overview
Table 68. Bayer Covid-19 Therapeutic Products, Services and Solutions
Table 69. Revenue (US$ Million) in Covid-19 Therapeutic Business of Bayer (2019-2024)
Table 70. Bayer Recent Developments
Table 71. Regeneron Pharmaceuticals Basic Information List
Table 72. Regeneron Pharmaceuticals Description and Business Overview
Table 73. Regeneron Pharmaceuticals Covid-19 Therapeutic Products, Services and Solutions
Table 74. Revenue (US$ Million) in Covid-19 Therapeutic Business of Regeneron Pharmaceuticals (2019-2024)
Table 75. Regeneron Pharmaceuticals Recent Developments
Table 76. Ascletis Pharma Basic Information List
Table 77. Ascletis Pharma Description and Business Overview
Table 78. Ascletis Pharma Covid-19 Therapeutic Products, Services and Solutions
Table 79. Revenue (US$ Million) in Covid-19 Therapeutic Business of Ascletis Pharma (2019-2024)
Table 80. Ascletis Pharma Recent Developments
Table 81. GlaxoSmithKline Basic Information List
Table 82. GlaxoSmithKline Description and Business Overview
Table 83. GlaxoSmithKline Covid-19 Therapeutic Products, Services and Solutions
Table 84. Revenue (US$ Million) in Covid-19 Therapeutic Business of GlaxoSmithKline (2019-2024)
Table 85. GlaxoSmithKline Recent Developments
Table 86. Gilead Sciences Basic Information List
Table 87. Gilead Sciences Description and Business Overview
Table 88. Gilead Sciences Covid-19 Therapeutic Products, Services and Solutions
Table 89. Revenue (US$ Million) in Covid-19 Therapeutic Business of Gilead Sciences (2019-2024)
Table 90. Gilead Sciences Recent Developments
Table 91. Pharmstandard Basic Information List
Table 92. Pharmstandard Description and Business Overview
Table 93. Pharmstandard Covid-19 Therapeutic Products, Services and Solutions
Table 94. Revenue (US$ Million) in Covid-19 Therapeutic Business of Pharmstandard (2019-2024)
Table 95. Pharmstandard Recent Developments
Table 96. Fujifilm Holdings Basic Information List
Table 97. Fujifilm Holdings Description and Business Overview
Table 98. Fujifilm Holdings Covid-19 Therapeutic Products, Services and Solutions
Table 99. Revenue (US$ Million) in Covid-19 Therapeutic Business of Fujifilm Holdings (2019-2024)
Table 100. Fujifilm Holdings Recent Developments
Table 101. Zhejiang Hisun Pharmaceutical Co. Ltd Basic Information List
Table 102. Zhejiang Hisun Pharmaceutical Co. Ltd Description and Business Overview
Table 103. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Products, Services and Solutions
Table 104. Revenue (US$ Million) in Covid-19 Therapeutic Business of Zhejiang Hisun Pharmaceutical Co. Ltd (2019-2024)
Table 105. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments
Table 106. Roche Basic Information List
Table 107. Roche Description and Business Overview
Table 108. Roche Covid-19 Therapeutic Products, Services and Solutions
Table 109. Revenue (US$ Million) in Covid-19 Therapeutic Business of Roche (2019-2024)
Table 110. Roche Recent Developments
Table 111. Sanofi Basic Information List
Table 112. Sanofi Description and Business Overview
Table 113. Sanofi Covid-19 Therapeutic Products, Services and Solutions
Table 114. Revenue (US$ Million) in Covid-19 Therapeutic Business of Sanofi (2019-2024)
Table 115. Sanofi Recent Developments
Table 116. Pfizer Basic Information List
Table 117. Pfizer Description and Business Overview
Table 118. Pfizer Covid-19 Therapeutic Products, Services and Solutions
Table 119. Revenue (US$ Million) in Covid-19 Therapeutic Business of Pfizer (2019-2024)
Table 120. Pfizer Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Covid-19 Therapeutic Downstream Customers
Table 124. Covid-19 Therapeutic Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Covid-19 Therapeutic Product Picture
Figure 2. Global Covid-19 Therapeutic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Covid-19 Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 4. Covid-19 Therapeutic Report Years Considered
Figure 5. Global Covid-19 Therapeutic Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Covid-19 Therapeutic Revenue in 2023
Figure 7. Covid-19 Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Immunotherapy Picture
Figure 9. Life Support Picture
Figure 10. Antiviral Medicine Picture
Figure 11. Plasma Therapy Picture
Figure 12. Others Picture
Figure 13. Global Covid-19 Therapeutic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Covid-19 Therapeutic Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Children
Figure 16. Product Picture of Adult
Figure 17. Global Covid-19 Therapeutic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Covid-19 Therapeutic Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Covid-19 Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Covid-19 Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Covid-19 Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Covid-19 Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Covid-19 Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Covid-19 Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Covid-19 Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Covid-19 Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Covid-19 Therapeutic Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Covid-19 Therapeutic Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Covid-19 Therapeutic Sales Value (%), (2019-2030)
Figure 30. United States Covid-19 Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Covid-19 Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Covid-19 Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Covid-19 Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Covid-19 Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Covid-19 Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 36. China Covid-19 Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Covid-19 Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 38. China Covid-19 Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Covid-19 Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Covid-19 Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Covid-19 Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Covid-19 Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Covid-19 Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Covid-19 Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Covid-19 Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Covid-19 Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Covid-19 Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 48. India Covid-19 Therapeutic Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Covid-19 Therapeutic Sales Value by Type (%), 2023 VS 2030
Figure 50. India Covid-19 Therapeutic Sales Value by Application (%), 2023 VS 2030
Figure 51. Covid-19 Therapeutic Industrial Chain
Figure 52. Covid-19 Therapeutic Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
